A magnetic resonance imaging coil specialized for imaging of the infant brain, spine, heart and torso has received 510(k) clearance from the U.S. Food and Drug Administration.
Cleveland-based Sree Medical Systems‘ obtained 510(k) clearance of its Infant Array, a receive-only radio-frequency coil array, in March, according to the FDA’s website.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Sree’s new product is intended for use with MRI systems from GE, Siemens and Philips, according to a document the company filed with the FDA.
Sree was founded in 1996 and focuses on products designed to facilitate MRI of pediatric patients, such as premature babies and newborns.
The company says its products provide higher resolution images in shorter scan times compared with competing devices.
The company’s other products include a head coil for neonatal patients and a neonatal ventilator for use during transport or MRI procedures.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Sree President Ravi Srinivasan didn’t return a call.
[Photo from flickr user Linda Cronin]
